Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 765-781

[2] Parkin DM(2009)A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer Eur J Cancer Care (Engl) 18 545-555

[3] Steliarova-Foucher E(2010)Chronic inflammation in the pathogenesis of benign prostatic hyperplasia Int J Androl 33 475-488

[4] McDowell ME(2013)Prostate specific antigen best practice statement: 2009 update J Urol 189 S2-S11

[5] Occhipinti S(2012)Landmarks in prostate cancer diagnosis: the biomarkers BJU Int 110 8-13

[6] Gardiner RA(2012)Landmarks in prostate cancer screening BJU Int 110 3-7

[7] Baade PD(2012)Hepatic acute phase proteins - Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling Eur J Cell Biol 91 496-505

[8] Steginga SK(2011)Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency Int J Oncol 39 1553-1558

[9] Fibbi B(2006)Secretory phospholipase A Prostaglandins Other Lipid Mediat 79 1-33

[10] Penna G(2007) of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Nat Rev Cancer 7 256-269

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 765-781

[2] Parkin DM(2009)A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer Eur J Cancer Care (Engl) 18 545-555

[3] Steliarova-Foucher E(2010)Chronic inflammation in the pathogenesis of benign prostatic hyperplasia Int J Androl 33 475-488

[4] McDowell ME(2013)Prostate specific antigen best practice statement: 2009 update J Urol 189 S2-S11

[5] Occhipinti S(2012)Landmarks in prostate cancer diagnosis: the biomarkers BJU Int 110 8-13

[6] Gardiner RA(2012)Landmarks in prostate cancer screening BJU Int 110 3-7

[7] Baade PD(2012)Hepatic acute phase proteins - Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling Eur J Cell Biol 91 496-505

[8] Steginga SK(2011)Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency Int J Oncol 39 1553-1558

[9] Fibbi B(2006)Secretory phospholipase A Prostaglandins Other Lipid Mediat 79 1-33

[10] Penna G(2007) of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Nat Rev Cancer 7 256-269